Product category:
Laboratory and scientific databases
News Release from: IDBS | Subject: Dat-Lab
Edited by the Laboratorytalk Editorial
Team on 16 May 2005
Acquisition leads to next-generation ELN
IDBS acquires Deffinity Solutions for its Dat-Lab electronic laboratory notebook that, it says, can be adapted to meet the needs of multiple scientific disciplines
IDBS has acquired the assets of privately-held Deffinity Solutions, a provider of compliant workflow software, including Dat-Lab, an innovative and extensible next generation electronic laboratory notebook (ELN) that can be adapted to meet the needs of multiple scientific disciplines "Regulatory compliance, 21 CFR part 11, and IP protection are fundamental to the commercial success of today's drug companies and are the drivers behind many current ELN initiatives" commented Neil Kipling, chairman and CEO of IDBS
This article was originally published on Laboratorytalk on 18 Nov 2002 at 8.00am (UK)
Related stories
Biopharma data management on enterprise platform
Biopharmaceutical software for integrated biological and chemical data management in drug discovery research is now available for use with AIX, IBM's Unix operating system
Streamline QC in screening
Major enhancements in the leading drug discovery data management software facilitate workflows for biologists, compound handlers and system administrators
"However, real success will only be achieved through the seamless integration of the ELN with solid data management, analysis and decision-making capability, that can accommodate the working methods and dialects specific to each scientific discipline within the drug discovery workflow.
"I believe this is where ELN must mature and become a part of a complete enterprise data management solution for drug creation".
IDBS considers itself a leading provider of integrated data management, analysis and decision-making software for the life sciences industry.
Further reading
Out-of-the-box automation
Collaboration brings fully automated assay system to laboratories without specialist IT support
Managing biopharma data in southern California
IDBS expands its southern Californian customer base, assisting biopharmaceutical companies to manage their research data and facilitate collaborations
This acquisition will enable it to provide secure and compliant protection of its customer's intellectual property while continuing to facilitate collaborative research between biologists and chemists, it says.
"Our insistence on open standards is based on a simple business imperative," said Paul Denny-Gouldson, CEO of Deffinity Solutions.
"Our client's IP vaults have to be securely and economically maintained for anything between five and 60 years.
"Most existing solutions rely heavily on proprietary approaches and technologies, and as such carry the risk of hidden costs over the longer term, eg, generating an IP audit trail in a patent dispute will be challenging if faced with version incompatibilities in proprietary technologies.
"Using standard technologies allows us to make the IP protection element of our system rock solid".
IDBS's ELN technology is based on open standard component architecture and integrates seamlessly with its existing chemistry technology and ActivityBase product set.
Meshing with existing workflows, it provides support of 21 CFR part 11 compliance, GxP enforcement, and electronic sign off right down to the level of a specific tasks.
The result is a fully integrated ELN solution that addresses the business critical compliance and data management requirements of research scientists operating in a highly competitive, and IP sensitive, market.
• IDBS: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
